Early Vascular Response to Ultrathin Biodegradable-Polymer Sirolimus-Eluting Stents for The Treatment of ST-Elevation Myocardial Infarction After Plaque Rupture

Early Vascular Response to Ultrathin Biodegradable-Polymer Sirolimus-Eluting Stents for The Treatment of ST-Elevation Myocardial Infarction After Plaque Rupture - BD-SES in STEMI

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000041324

Enrollment

Registered

2020-08-06

Start date

2020-08-06

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ST elevated myocardial infarction

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Consecutive patients with STEMI who underwent PCI.

Exclusion criteria

Exclusion criteria: cardiogenic shock, left main disease at the culprit lesion, reference vessel diameter less than 2.0 or 4.5 mm and more, chronic kidney disease defined as a serum creatinine 2.0 mg/dL and more, maintenance dialysis, life expectancy less than two years, planned surgery within three months, adverse reactions to aspirin or clopidogrel previously, warfarin intake before STEMI onset, age less than 20 years, pregnancy, and a previously treated culprit lesion in the stented segment. We further excluded patients who did not undergo OCT, did not show plaque rupture on OCT, and received DES other than BP-SES, patients who do not consent the study.

Design outcomes

Primary

Measure	Time frame
Percentage of uncovered strut at 2 weeks after stent placemnent.	—

Countries

Japan

Contacts

Public ContactTsujita Hiroaki

Showa University School of Medicine Division of Cardiology, Department of Medicine

h.tsujita.19800517@hotmail.co.jp03-3784-8664

Outcome results